- Open
- 349.40
- High
- 351.50
- Low
- 348.20
- Close
- 349.90
- Change
- +5.50 (1.60%)
- Volume
- 17,662,770
| 1 Oct 2026 | 09:00:01 | Total Voting Rights and Capital |
| 24 Sept 2026 | 11:45:00 | Director/PDMR Shareholding |
| 18 Sept 2026 | 12:00:01 | Director/PDMR Shareholding |
| 1 Sept 2026 | 09:00:00 | Total Voting Rights and Capital |
| 19 Aug 2026 | 10:05:01 | Cash Tender Offer - Pricing, Expiration and Result |
| 31 Mar 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 13 Mar 2026 | Haleon plc Annual Report and Form 20-F 2025 (ESEF) | |
| 13 Mar 2026 | Haleon plc Annual Report and Form 20-F 2025 |
Haleon plc is a consumer healthcare company that focuses on delivering everyday health solutions. It operates in six key categories: Oral Health, Vitamins, Minerals & Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The company generates revenue by selling a portfolio of well-known brands that cater to consumers seeking health and wellness products. Haleon serves a global market, emphasizing sustainable growth and improved health outcomes through science and consumer insights.
Lord Sassoon has interests in this issuer
| 1 Oct 2026 | 09:00:01 | Total Voting Rights and Capital |
| 24 Sept 2026 | 11:45:00 | Director/PDMR Shareholding |
| 18 Sept 2026 | 12:00:01 | Director/PDMR Shareholding |
| 1 Sept 2026 | 09:00:00 | Total Voting Rights and Capital |
| 19 Aug 2026 | 10:05:01 | Cash Tender Offer - Pricing, Expiration and Result |
| 31 Mar 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 13 Mar 2026 | Haleon plc Annual Report and Form 20-F 2025 (ESEF) | |
| 13 Mar 2026 | Haleon plc Annual Report and Form 20-F 2025 |
Haleon plc is a consumer healthcare company that focuses on delivering everyday health solutions. It operates in six key categories: Oral Health, Vitamins, Minerals & Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The company generates revenue by selling a portfolio of well-known brands that cater to consumers seeking health and wellness products. Haleon serves a global market, emphasizing sustainable growth and improved health outcomes through science and consumer insights.
Lord Sassoon has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £75.88bn | +0.1% | |
HLNHaleon plc | £30.82bn | +0.0% |
| £4.18bn | -0.1% | |
| £2.04bn | +0.3% | |
| £284m | -0.1% | |
| £3m | -0.9% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £75.88bn | +0.1% | |
HLNHaleon plc | £30.82bn | +0.0% |
| £4.18bn | -0.1% | |
| £2.04bn | +0.3% | |
| £284m | -0.1% | |
| £3m | -0.9% |